TGFB1 and colorectal carcinoma: It has been previously reported that components of the TGFβ-signaling pathway are mutated in 27% of non-hypermutated tumors and 87% of hypermutated tumors [4], and that inactivation of the pathway is a common event in CRC tumorigenesis [4].